.
John Hunter, PhD
Postdoctoral fellow, University of Texas Southwestern Medical Center
Recipient, 2015 Pancreatic Cancer Action Network – NCI Frederick National
Laboratory for Cancer Research KRAS Fellowship funded in memory of Samuel Stroum
|
NCI Frederick National Laboratory for Cancer Research and Pancreatic Cancer Action Network Announce
2016 KRAS Fellowship and KRAS Travel Scholarship
Dear RAS research community,
The National Cancer Institute's (NCI) Frederick National Laboratory for Cancer Research (FNLCR) and the Pancreatic Cancer Action Network have joined together again to further cutting edge research on pancreatic cancer and KRAS that integrates with NCI's RAS Initiative. For 2016, two types of awards are offered.
KRAS Fellowship
- Supports a postdoctoral fellow, clinical research fellow or the equivalent to conduct KRAS research that is directly applicable and relevant to pancreatic cancer with aims aligned with the Structural Biology and Biochemistry priority area of the RAS Initiative
- Provides $45,000 in research support over one-year
- Additional funding provided for scientific mentoring and career development activities, including site visits to FNLCR in Frederick, Maryland and technical support by the RAS team
- Two Fellowships expected to be awarded
New! KRAS Travel Scholarship
- Provides travel support to a researcher at any career stage at or after the postdoctoral level to visit FNLCR in Frederick, Maryland to pursue KRAS research that is directly applicable and relevant to pancreatic cancer and is compatible with one or more of the six priority areas of the RAS Initiative
- Provides $12,000 over one-year
- Two Travel Scholarships expected to be awarded
Applications are now being accepted and are due Friday, November 6, 2015 at noon, Eastern Time.
The Fellowship and Travel Scholarship will be awarded using a competitive, rigorous peer-review process that is coordinated by the Pancreatic Cancer Action Network and the National Cancer Institute FNLCR. Questions? Please email grants@pancan.org.
The RAS Initiative
The National Cancer institute's RAS Initiative was launched in 2013 to deepen knowledge of several aspects of RAS genes – their protein products, role in cell signaling, and functions in health and disease – with the explicit goals of improving treatment, diagnosis, and prevention of the many human cancers driven by mutant RAS genes. The Initiative operates as a research hub based at the NCI Frederick National Laboratory for Cancer Research (FNLCR) in Frederick, Maryland, with spokes reaching into all corners of the extramural research community. The RAS Initiative is led by Dr. Frank McCormick, a distinguished RAS investigator from the University of California, San Francisco, and managed for NCI by Leidos Biomedical Research, Inc. |
|
|
|
 |
|
|
|
|
Frederick National Laboratory for Cancer Research
8560 Progress Drive
Frederick, MD 21701
301-496-4345
Pancreatic Cancer Action Network
1500 Rosecrans Ave., Suite 200
Manhattan Beach, CA 90266
877-272-6226 |
|
|
|
|
|
|
|
|
